Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(18/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(18/week)
News
United States
(572/week)
Manufacturing
(420/week)
Energy
(315/week)
Technology
(459/week)
Other Manufacturing
(342/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
NeuroVive Pharmaceutical AB
Apr 27, 2018
Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
Apr 20, 2018
NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference
Apr 20, 2018
NeuroVive's Board Members, Senior Executives and Employees Will Subscribe Units in the Ongoing Rights Issue
Apr 18, 2018
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases
Apr 17, 2018
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
Feb 20, 2018
NeuroVive Pharmaceutical AB Year End Report January - December 2017
Feb 15, 2018
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
Feb 15, 2018
NeuroVive Decides on a Rights Issue for Continued Drug Development
Jan 29, 2018
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project
Jan 03, 2018
NeuroVive to Present at the 10th Annual Biotech Showcase Conference
Dec 13, 2017
NeuroVive's KL1333 Program Granted Orphan Drug Designation by the European Commission
Dec 11, 2017
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333
Nov 30, 2017
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone
Nov 30, 2017
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
Nov 21, 2017
NeuroVive Pharmaceutical AB Interim Report January - September 2017
Nov 15, 2017
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference
Nov 07, 2017
NeuroVive Board Chair Resigns, New Chair Elected
Nov 03, 2017
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million
Oct 31, 2017
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development
Oct 18, 2017
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research
‹‹
Page 2
››
Latest News
May 2, 2024
Hess Midstream LP to Participate in Investor Conferences
May 2, 2024
Valaris Reports First Quarter 2024 Results
May 2, 2024
Materion Corporation Reports First Quarter 2024 Financial Results
May 2, 2024
Cactus Announces First Quarter 2024 Results
May 2, 2024
EnerSys Announces Date of Fourth Quarter and Full Year Fiscal 2024 Financial Results Release and Conference...
May 2, 2024
Eversource Energy Reports First Quarter 2024 Results
May 2, 2024
ATS to Participate in TD Cowen’s 2nd Annual Sustainability Conference
May 2, 2024
Distribution Solutions Group’s Operating Company, Lawson Products, Executes a Strategic Acquisition of S&...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events